Sponsor:
Sutro Biopharma, Inc.
Code:
NCT05200364
Conditions
Ovarian Cancer
Ovarian Carcinoma
Ovary Cancer
Fallopian Tube Cancer
Primary Peritoneal Carcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
STRO-002
Bevacizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-04. This information was provided to ClinicalTrials.gov by Sutro Biopharma, Inc. on 2024-11-07.